Article Sidebar
Main Article Content
Abstract
Background: The breast cancer progression and chemotherapy side effects not only cause problems in mental status, but also the patient's physical status. This is related to a deteriorating quality of life and a worse prognosis. Physical exercise can improve physical status, mental status, and quality of life.
Methods: Experimental pre- and post intervention research with a control group was conducted on breast cancer patients to determine the effect of progressive muscle relaxation on the improvement of body composition, depression status, and quality of life for breast cancer patients during chemotherapy at RSMH on February 2019 - February 2020.
Results: Progressive muscle relaxation (PMR) can improve body composition (p = 0.000), reduce the degree of depression (p = 0.000), improve global health status (p = 0.013), physical functioning (p = 0.002), emotional functioning (p = 0.009), social functioning (p = 0015), body image (0.000), sexual function (p = 0.05), future perspective (p = 0.006), and decreased fatigue (p = 0.00), nausea and vomiting (p = 0.002 ), pain (0.000), insomnia (0.002), appetite loss (p = 0.000), breast symptoms (p = 0.000), arm symptoms (p = 0.000), hair loss (p = 0.000), and therapy side effects (p = 0.000).
Conclusion: Progressive muscle relaxation has a significant effect on improving body composition, depression status, and quality of life for breast cancer patients during chemotherapy.
Keywords
Article Details
Authors retain copyright and grant Sriwijaya Journal of Surgery the non-exclusive right of first publication.
The journal’s publishing license is Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). Reuse requires appropriate attribution, must be non-commercial, and adaptations must be shared under the same license.
Authors may deposit their submitted manuscript, accepted manuscript, and published version without an embargo, with acknowledgement of the journal and a link to the version of record.
See the Copyright and Licensing Policy for details.